What this record means
The record shows that the application for RYZELBRI (Serial 88578951) was abandoned on June 2, 2020, after the applicant, Ovid Therapeutics Inc., failed to respond to an Office action, so the mark is not live or registered. The only goods listed are “pharmaceutical preparations for the treatment of developmental disorders; pharmaceutical preparations for the treatment of neurological disorders” in International Class 005, meaning a similar name would raise the closest concern in the pharmaceutical field, especially for products treating those conditions. The record does not give Ovid Therapeutics control over every use of the word “RYZELBRI” in unrelated industries or contexts. Because the application was on the Principal Register and never moved to the Supplemental Register, there is no supplemental‑register sequence to note. The latest meaningful event is the abandonment notice on the same June 2, 2020 date, and no enforcement actions appear in the history. I'd treat this as a moderate concern if you plan a pharma‑related name in the same therapeutic area.
Informational only - not legal advice.